Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
1.040
-0.010 (-0.95%)
Jul 22, 2024, 10:00 AM EDT - Market open
Cytosorbents Employees
Cytosorbents had 186 employees as of December 31, 2023. The number of employees decreased by 12 or -6.06% compared to the previous year.
Employees
186
Change (1Y)
-12
Growth (1Y)
-6.06%
Revenue / Employee
$197,238
Profits / Employee
-$148,061
Market Cap
56.48M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Neuronetics | 203 |
LENSAR | 130 |
Adlai Nortye | 127 |
Mural Oncology | 117 |
CollPlant Biotechnologies | 75 |
Passage Bio | 58 |
Rallybio | 43 |
OKYO Pharma | 8 |
CTSO News
- 5 days ago - CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress - GlobeNewsWire
- 20 days ago - CytoSorbents Secures $20 Million Credit Facility - GlobeNewsWire
- 6 weeks ago - CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting - GlobeNewsWire
- 2 months ago - CytoSorbents Reports First Quarter 2024 Results - GlobeNewsWire
- 3 months ago - CytoSorbents to Report First Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting - GlobeNewsWire
- 4 months ago - CytoSorbents Reports Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 4 months ago - CytoSorbents to Report Fiscal 2023 Operating and Financial Results - GlobeNewsWire